Briacell Therapeutics Corp (BCT : TSX)
Common Stock
$4.23
CAD
-0.03 (-0.70%)
Last updated: 2026-06-23
BCT
Briacell Therapeutics Corp
WealthAwesomePerformance
1 Day
-0.70%
1 Week
+6.28%
1 Month
-11.69%
YTD
-56.92%
Key Statistics
Market Cap
$37.24M
52W High
$42.30
52W Low
$3.68
P/E Ratio
-
50 Day MA
$5.03
200 Day MA
$9.23
Beta
1.64
Dividend Yield
-
Technical Indicators
Price vs 50-Day SMA
Price vs 200-Day SMA
Recent Price History
| Date | Open | High | Low | Close | Adj Close | Volume |
|---|---|---|---|---|---|---|
| 6/23/2026 | $4.41 | $4.41 | $4.23 | $4.23 | $4.23 | 2,502 |
| 6/22/2026 | $4.19 | $4.34 | $4.19 | $4.26 | $4.26 | 7,239 |
| 6/19/2026 | $4.12 | $4.12 | $4.11 | $4.11 | $4.11 | 301 |
| 6/18/2026 | $4.02 | $4.19 | $4.02 | $4.11 | $4.11 | 4,051 |
| 6/17/2026 | $4.06 | $4.06 | $3.95 | $3.95 | $3.95 | 513 |
| 6/16/2026 | $3.86 | $4.04 | $3.83 | $3.98 | $3.98 | 6,505 |
| 6/15/2026 | $4.01 | $4.01 | $3.81 | $3.90 | $3.90 | 6,675 |
| 6/12/2026 | $3.84 | $4.00 | $3.75 | $3.80 | $3.80 | 10,732 |
| 6/11/2026 | $4.02 | $4.02 | $3.68 | $3.85 | $3.85 | 24,114 |
| 6/10/2026 | $4.27 | $4.27 | $4.02 | $4.03 | $4.03 | 3,656 |
Analyst Price Targets
Based on analyst covering BCT
Wall Street analysts forecast BCT stock price to rise 372.8% over the next 12 months.
Consensus
No RatingAvg. Target
C$20.00
+372.8% Upside
Current Price
C$4.23
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on BCT's historical volatility
30-Day Vol
113.3%
Annualized
90-Day Vol
85.5%
Annualized
Trend (90d)
-50.0%
Annualized drift
90d Mean
C$3.54
Expected price
| Horizon | Expected | 68% Range (1ฯ) |
|---|---|---|
| 30 trading days | C$3.99 | C$2.70 โ C$5.89 |
| 60 trading days | C$3.76 | C$2.16 โ C$6.53 |
| 90 trading days | C$3.54 | C$1.80 โ C$6.96 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ยฑ1ฯ, 95% band = ยฑ2ฯ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
About Briacell Therapeutics Corp
BriaCell Therapeutics Corp., a pre-clinical stage immuno-oncology company, engages in developing targeted immunotherapies to transform cancer care. Its lead candidate is Bria-IMT, a targeted immunotherapy program against end-stage breast cancer that is in Phase 3 clinical trials. The company develops Bria-OTS, a personalized off-the-shelf immunotherapy; and a soluble CD80 protein therapeutic that acts as a stimulator of the immune system and an immune checkpoint inhibitor. It has a license agreement with the University of Maryland, Baltimore County to develop and commercialize soluble CD80 as a biologic agent for the treatment of cancer. BriaCell Therapeutics Corp., has a collaboration with MSK Accelerator to accelerate theclinical development of Bria-OTS+ for multiple cancer indications including metastatic breast cancer, prostate cancer, and other cancers. The company is headquartered in West Vancouver, Canada.
Financials
- Revenue (TTM)
- $0
- EBITDA
- $-31.92M
- Profit Margin
- 0.00%
- ROE (TTM)
- -175.26%
- EPS (Diluted)
- -1.19
- Book Value
- 5.95
Classification
- Sector
- Health Care
- Industry
- Biotechnology
- Group
- Pharmaceuticals, Biotechnology & Life Sciences
๐ Recent Splits
1-for-10
Aug 25, 2025
1-for-15
Jan 29, 2025
1009-for-1000
Sep 5, 2023
Advertisement
7 stocks to buy and hold forever
Blue-chip dividend stocks for long-term wealth building.
Get the FREE ReportExplore More
Common Questions About BCT
Articles Featuring BCT.TO
Latest articles and analysis covering BCT.TO
Why Briacell Therapeutics Corp stock is gaining today
Briacell Therapeutics Corp's stock gained 1.89% in the latest trading session, closing at CA$4.31. This increase reflects a potential shift in investor sentiment as the company continues to innovate in personalized immunotherapy.
Why Briacell Therapeutics Corp stock is rising today
Briacell Therapeutics Corp's stock surged by 4.62% in the last trading session, closing at CA$4.30. This increase highlights investor confidence in the company's strategic moves and its innovative approach to cancer treatment.
Why Briacell Therapeutics Corp stock is rising today
Briacell Therapeutics Corp (BCT.TO) experienced a 4.05% increase in its stock price, closing at CA$4.11. This rise may reflect growing investor confidence in its innovative cancer therapies, particularly in the context of recent developments.
Why Briacell Therapeutics Corp stock is rising today
Briacell Therapeutics Corp's stock rose by 2.28% in the latest trading session, closing at CA$4.04. This uptick reflects increasing investor interest in the company's innovative cancer treatment solutions.
Why Briacell Therapeutics Corp stock is tanking today
Briacell Therapeutics Corp's stock has dropped 0.75% in the latest trading session, reflecting investor concerns amid a lack of significant news. With a market cap of CA$33.9 million, the company faces challenges in the competitive biotech sector.
Why Briacell Therapeutics Corp stock is rising today
Briacell Therapeutics Corp's stock has risen by 2.82% in the last session, closing at CA$4.01. This increase signals investor optimism surrounding the company's advancements in immunotherapy for cancer treatment.
Why Briacell Therapeutics Corp stock is rising today
Briacell Therapeutics Corp's stock has risen by 3.38% to CA$3.98, reflecting positive investor sentiment towards its innovative cancer treatments.
Why Briacell Therapeutics Corp stock is plummeting today
Briacell Therapeutics Corp's stock plummeted by 8.19% today, raising concerns about its future as the company navigates a challenging market landscape.
10 Best Canadian Biotech Stocks (Jun 2026)
Biotech has been one of the most promising engines of innovation in the field of healthcare and medicine. Consequently, it's also an avenue where a lot of big money is moving in (institutional investors, government funding, etc.). The global biotech market size is expected to reach a trillion dollar
![10 Best Canadian Biotech Stocks ([currentmonthyear])](https://lhajohzwizrsjmumhpjg.supabase.co/storage/v1/object/public/wealth-awesome/site-media/best-canadian-biotech-stocks_8-1.jpg)